Elutia ELUT
NASDAQ ELUT
$0.81 +0.01 (+1.76%)
As of: Sep 10, 2026 · 1:49 PM EDT

Elutia (ELUT) Operating Income Growth (3y) (2022 - 2026)

Analysis

Elutia (ELUT) Operating Income Growth (3y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Abbott Laboratories 180.79 Bn 175.19 Bn 7.27 Bn 3.16%
2 Intuitive Surgical 127.05 Bn 121.83 Bn 1.96 Bn 28.02%
3 Medtronic 117.00 Bn 108.18 Bn 6.34 Bn 11.63%
4 Stryker 103.78 Bn 100.31 Bn 4.50 Bn 19.80%
5 Boston Scientific 63.50 Bn 62.96 Bn 3.85 Bn 31.84%
6 Edwards Lifesciences 49.72 Bn 45.46 Bn 1.35 Bn 24.88%
7 Alcon 32.98 Bn 31.52 Bn 1.68 Bn -65.59%
8 Dexcom 32.05 Bn 30.10 Bn 830.00 Mn 35.44%
9 Steris 20.68 Bn 20.19 Bn 684.20 Mn 13.06%
10 Elutia 36.01 Mn 16.11 Mn 1.45 Mn -8.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.04%
Mar 31, 2026 8.69%
Dec 31, 2025 11.69%
Sep 30, 2025 16.57%
Jun 30, 2025 -0.74%
Mar 31, 2025 0.70%
Dec 31, 2024 1.32%
Sep 30, 2024 -9.56%
Jun 30, 2024 -22.80%
Mar 31, 2024 -31.85%
Dec 31, 2023 -29.00%
Sep 30, 2023 -39.92%
Jun 30, 2023 -18.80%
Mar 31, 2023 -37.87%
Dec 31, 2022 -43.72%
Sep 30, 2022 -69.33%